newsfilter
← Latest News
GlobeNewswire·

Ultragenyx to Participate at Investor Conferences in London

  • Ultragenyx Pharmaceutical Inc. announced participation in two upcoming investor conferences on November 16 & 17, 2026.
  • CEO Emil Kakkis, CMO Eric Crombez, & CFO Howard Horn will participate in fireside chats & host 1x1 meetings at the UBS Global Biopharma Conference 2026 on November 16.
  • The same executive team will present at the 2026 Jefferies Global Healthcare Conference on November 17.
  • Live & archived webcasts of the fireside chats will be available on the company's investor relations website.
  • Ultragenyx is a biopharmaceutical company focused on novel therapies for serious rare & ultra-rare genetic diseases.
  • Investor inquiries can be directed to Joshua Higa at ir@ultragenyx.com.
Company
Ultragenyx Pharmaceutical Inc.
Keywords
Nasdaq:RARE, Ultragenyx Pharmaceutical Inc.